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Abstract
Introduction: HIV incidence is an important measure for monitoring the development of the epidemic, but it is difficult to
ascertain. We combined serial HIV prevalence and mortality data to estimate HIV incidence among key affected populations
(KAPs) in China.
Methods: Serial cross-sectional surveys were conducted among KAPs from 2010 to 2014. Trends in HIV prevalence were
assessed by the Cochran-Armitage test, adjusted by risk group. HIV incidence was estimated from a mathematical model that
describes the relationship between changes in HIV incidence with HIV prevalence and mortality.
Results: The crude HIV prevalence for the survey samples remained stable at 1.1 to 1.2% from 2010 to 2014. Among drug users
(DUs), HIV prevalence declined from 4.48 to 3.29% (pB0.0001), and among men who have sex with men (MSM), HIV prevalence
increased from 5.73 to 7.75% (pB0.0001). Changes in HIV prevalence among female sex workers (FSWs) and male patients
of sexually transmitted disease clinics were more modest but remained statistically significant (all pB0.0001). The MSM
population had the highest incidence estimates at 0.74% in 2011, 0.59% in 2012, 0.57% in 2013 and 0.53% in 2014. Estimates of
the annual incidence for DUs and FSWs were very low and may not be reliable.
Conclusions: Serial cross-sectional prevalence data from representative samples may be another approach to construct
approximate estimates of national HIV incidence among key populations. We observed that the MSM population had the highest
incidence for HIV among high-risk groups in China, and we suggest that interventions targeting MSM are urgently needed to
curb the growing HIV epidemic.
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Introduction
In 2012, there were approximately 35 (33.2 to 37.2) million
people living with HIV and 2.1 (1.9 to 2.4) million new
infections globally [1]. HIV incidence is a useful indicator for
monitoring the spread of the epidemic and the effectiveness
of HIV/AIDS prevention and treatment efforts. However, direct
calculation of HIV incidence from epidemiological surveys has
proven to be a difficult methodological issue.
Although considered the most traditional way to measure
HIV incidence, prospective cohort studies are expensive, time
consuming and not typically representative of nationwide
trends. Since the 1990s, laboratory-based incidence assays
have been developed and introduced into cross-sectional
surveys [25], and improvements in methods and algorithms
have yielded more reliable estimates of new HIV infections
[6,7]. However, conducting representative sampling and
complicated algorithmic approaches to estimate HIV incidence
at a national level is prohibitive for countries with highly
concentrated HIV epidemics, such as China [8,9]. UNAIDS has
also recommended mathematical models for estimating
national HIV incidence rates, such as the Estimation and
Projection Package (EPP) [1012], Spectrum [1315], Asian
Epidemic Model (AEM) [16] andModes of Transmission (MOT)
model [17]. However, the application of thesemodels is limited
by the difficulty of defining subpopulations and sub-epidemics
in countries with concentrated epidemics and a lack of valid
parameter estimates for many resource-limited subnational
areas.
In a relatively closed population, HIV prevalence is
affected by both incidence and case fatality. Because cross-
sectional surveys can be used to capture HIV prevalence and
HIV-related mortality, methods have been proposed for
estimating incidence based on these observed measures.
Previous research in sub-Saharan African countries has
shown that sufficiently accurate estimates of incidence can
be generated from cross-sectional prevalence data on general-
ized epidemics [1821].
The HIV epidemic in China is primarily concentrated among
high-risk groups. Drug users (DUs) [22], female sex workers
(FSWs) [23,24] and men who have sex with men (MSM)
[25,26] are the three main subpopulations affected by HIV in
China. In order to monitor the HIV epidemic, China established
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the HIV Sentinel Surveillance System (HSSS) in 1995 to con-
duct cross-sectional surveys among eight targeted subpopula-
tions designated as key affected populations (KAPs) [22,27].
Following a rapid expansion of the HSSS in 2010 [28],
this system is now a nationwide surveillance network, which
provides a way to record changes in the annual HIV prevalence
among high-risk populations, including DUs, FSWs and MSM.
The aim of this paper is to describe trends in HIV prevalence
among high-risk populations in China and to estimate inci-
dence using a mathematical model.
Methods
HIV Sentinel Surveillance
The introduction and development of the HSSS has been
described in other papers [2730]. The number of sentinel
sites has risen from 42 initial sites in 1995 to 101 sites in 2000
and to 600 sites in 2009. In 2010, the HSSS was further scaled
up by introducing new sentinel sites in areas where high-
risk groups were most concentrated. In total, 1888 sentinel
sites were established within 300 cities across 31 provinces.
The HSSS targets the following eight KAPs: DUs, MSMs, FSWs,
male patients of sexually transmitted disease (STD) clinics,
pregnant women, long-distance truck drivers, college stu-
dents and male migrant workers [28]. This study analysed
survey data collected from 2010 to 2014 (Figure 1) at sentinel
sites nationwide.
Cross-sectional surveys were conducted among the eight
KAPs from April to June each year. The sample size for each
surveillance site was 400 participants across the KAPs except
for college students. Separate sites were established at
colleges and had a target of reaching 800 students. Venue-
based sampling in the first year was used to randomly select
sites based on location and opening time, and participants
were recruited consecutively at venues. Surveys were con-
ducted at the same sentinel sites each year, and the annual
target sample size at each site was fixed. After providing
informed consent, participants completed an anonymous,
structured questionnaire which covered demographic infor-
mation, HIV-related behaviours and HIV testing history. HIV
testing was recommended for all participants. Testing was
done by two enzyme-linked immunosorbent assays (ELISA),
and participants were not informed of their result unless they
requested it by a self-defined encryption code [28].
Participants with two positive ELISA results in the surveil-
lance system were not reported to the national HIV case
reporting system until the participants were notified and
received western blot confirmatory testing [31]. Per national
policy, individuals with a confirmed HIV diagnosis are then
registered in the national case reporting system, assigned a
unique identification number, followed up for health consults
at least every six months and initiated on antiretroviral
therapy (ART) if eligible. Patient data, including CD4 count
[32], ART regimen [33], HIV/AIDS clinical stage and death, are
uploaded to the case reporting system by the follow-up
healthcare providers [33]. HIV case fatality was calculated
by the proportion of observed deaths in the following year
among HIV-positive individuals diagnosed through the cross-
sectional surveys and reported to the case reporting system.
The HIV prevalence and interquartile range (IQR) among
each target population was calculated at the site and national
levels for each year from 2010 to 2014. Chi-square tests were
performed to assess the differences among subgroups within
KAPs. Trends in HIV prevalence were assessed by the Cochran-
Armitage test using SAS software version 9.3 (SAS Institute
Inc., Cary, NC, USA).
Estimation of HIV incidence
To estimate HIV incidence, the DU HIV prevalence was
adjusted by the distribution of DU types: ‘‘traditional’’ DU,
club DU and user of both traditional and club drugs.Traditional
drugs are defined in sentinel surveillance guidelines as heroin,
Figure 1. Study period from 2010 to 2014. DUsdrug users, FSW female sex workers, MSMmen who have sex with men,
STDmale patients of sexually transmitted disease clinics, PRGpregnant women, DRV long-distance truck drivers, YSTyoung
(college-age) students, MOPmale mobile population (migrant workers).
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opium, opiate analgesics, cocaine and marijuana. Heroin use
through injection accounts for the majority of drug use in
China. Club drugs include methamphetamine, ketamine, 3,4-
methylenedioxy-N-methylamphetamine (MDMA) and ‘‘Magu’’
pills, which are a mixture of methamphetamine and caffeine
[22]. The HIV prevalence among MSM and male STD patients
were adjusted by cities, and the FSW HIV prevalence was
adjusted by venue (low-fee or other).
We estimated incidence utilizing serial prevalence esti-
mates and HIV survival based on the method described by
Brookmeyer and Konikoff [34]. Generally, the method pro-
poses that changes in HIV prevalence can be related to
incidence and survival through a balancing equation. Suppose
two cross-sectional surveys for HIV prevalence were con-
ducted at times t1 and t2 in a key population. Let P1 indicate
the HIV prevalence at time t1 (i.e. the proportion of living
persons who are HIV-infected), and Q11-P1 the proportion
of living persons at time t1 that are not infected but at risk
of HIV infection. Similarly, P2 is the HIV prevalence at t2. The
relative survival (R) of the HIV-infected population (relative
to the whole targeted population) is the ratio of the survival
probability that HIV-infected persons survive the period d
(where d t2t1) divided by the corresponding probability
for the entire population. It is shown30 that incidence can be
estimated from the equation
I ¼ ðP2  P1RÞ=Q1d (1)
If P2BP1R, then we set I to a low value, such as B0.001,
indicating a low estimate of new HIV infections. Because of
lowmortality among the general HIV-negative population over
1 year, we assumed that the survival of the entire population is
approximately 1; thus, relative survival R is equal to 1 minus
the case fatality.
Studies have found that average duration of engagement
as a FSW in China is approximately 3 to 5 years, which means
that one-fifth to one-third of FSWs will leave this population
each year (i.e. turnover) [35]. We assumed that turnover
occurs randomly irrespective of HIV status, new entering
FSWs are HIV-negative, and the total FSW population size is
constant over years. Thus, among FSWs, the relative survival
(R) is the combination parameter of turnover (Ti) and case
fatality (Fi). The relative survival (R) of HIV among FSWs can
be expressed as
R ¼ ð1  TiÞ  ð1  FiÞ (2)
Ethics
This study was reviewed and approved by the Institutional
Review Board of the National Centre for AIDS/STD Preven-
tion and Control, Chinese Centre for Disease Control and
Prevention. All participants providedwritten informed consent
before participating in the surveys. Study participants were
reimbursed 50 RMB (8 USD) for the cost of transportation.
Results
HIV prevalence
Cross-sectional surveys were conducted annually from 2010
to 2014. The sample sizes of the surveys were 731,916 in
2010, 757,543 in 2011, 772,681 in 2012, 777,084 in 2013 and
749,116 in 2014. The crude HIV prevalence estimates for all
participants were 1.10% for 2010, 1.07% for 2011, 1.12% for
2012, 1.13% for 2013 and 1.17% for 2014 (Table 1).
The geographical distribution of HIV prevalence among
DUs, FSWs, MSM and male patients of STD clinics in 2014 is
presented in Figure 2. Among DU participants from 299
survey sites in 2014, 168 sites reported an HIV prevalence
B1%, 70 sites reported between 1 and 5%, 61 sites reported
between 5 and 10% and 39 sites reported 10%. Almost
all sites with DU HIV prevalence higher than 5% were in the
provinces of Guangxi, Sichuan, Yunnan and Xinjiang. Stratified
by drug types, DUs who used only traditional drugs had
higher HIV prevalence (4.86%; 3440/70,724) than club DUs
(0.47%; 168/35,811) and concurrent users of both traditional
and club drugs (2.43%; 3829/9099; pB0.0001).
In 2014, FSW were surveyed at 499 sites. The HIV
prevalence at 473 sites was less than 1%, and the remaining
26 sites had a prevalence between 1 and 5%. FSWs who
worked at low-fee venues had a higher HIV prevalence
(0.36%; 211/58,976) than other FSWs (0.08%; 98/126,046;
pB0.0001).
All sites that surveyed MSM, except for two, identified
HIV-infected individuals. MSM in large cities experienced a
higher HIV prevalence (10.73%; 1534/14,297) than MSM in
other cities (6.26%; 1793/28,654; pB0.0001).
Among male patients of STD clinics at 368 sites, 274 sites
reported B1% HIV prevalence, 84 sites reported between 1
and 5%, and 10 sites reported higher than 5%. Participants
from large cities had a higher prevalence (1.92%; 368/19,187)
than other cities (0.56%; 694/124,719; pB0.0001).
Trends in HIV prevalence and case fatality
From 2010 to 2014, HIV prevalence among DUs decreased
from 4.50 to 3.31% while the prevalence among MSM
increased from 5.73 to 7.75%. HIV prevalence among
FSWs remained low with slight fluctuations between 0.17
and 0.24%. Among male patients of STD clinics, the preva-
lence increased from 0.43 to 0.74% (Table 1). The Cochran-
Armitage test for trend showed that the changes in HIV
prevalence among DUs (pB0.0001), FSWs (pB0.0001), MSM
(pB0.0001) andmale patients of STD clinics (pB0.0001)were
significant.
From 2011 to 2013, the respective annual case fatality
(Table 2) among the surveyed DUs was 1.6% (N3161),
1.7% (N3321) and 2.4% (N2996); and among FSWs,
the annual case fatality was 0.9% (N212), 0.5% (N384)
and 0.3% (N293). Among MSM, the case fatality was 1.4%
(N1025), 0.9% (N1610) and 1.3% (N1502); and
among male patients of STD clinics, the case fatality was
5.3% (N243), 2.5% (N398) and 2.1% (N375).
HIV incidence
Based on Equations (1 and 2), we estimated the HIV incidence
from 2011 to 2014 among DUs, FSWs, MSM and male patients
of STD clinics (Figure 3). An adjusted HIV prevalence (P’) was
used during HIV incidence estimation. We calculated that the
DU HIV incidence estimates were B0.001% in 2011, 0.09%
in 2012, 0.10% in 2013 and B0.001% in 2014. FSWs had
an estimated incidence of 0.03% in 2011, 0.06% in 2012,
B0.001% in 2013 and 0.01% in 2014. Among MSM, the
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incidence estimates were 0.74% in 2011, 0.59% in 2012,
0.57% in 2013 and 0.53% in 2014. Among male patients of
STD clinics, the incidence was 0.04% in 2011, 0.08% in 2012,
0.04% in 2013 and 0.19% in 2014. Our data showed that the
HIV incidence was notably high among MSM in large cities
at about 0.95% in 2011, 1.25% in 2012, 0.98% in 2013 and
0.91% in 2014. In comparison, the incidence among MSM in
smaller cities was 0.31% in 2011, 0.28% in 2012, 0.39% in
2013 and 0.36% in 2014.
Discussion
Measuring incidence is a valuable method for describing and
monitoring changes in the HIV epidemic. Using data from a
series of annual cross-sectional surveys in China from 2010 to
2014, we examined changes in HIV prevalence across key
high-risk groups. We produced estimates of HIV incidence in
the context of a centralized epidemic based on the relation-
ship among prevalence, case fatality and incidence [34].
In 2010, the Chinese national HSSS was widely scaled
up across the country to better characterize and monitor the
HIV epidemic [28]. All sentinel sites conduct annual HIV
prevalence surveys, targeting key populations at high risk for
HIVacquisition.We found that theMSM population, especially
MSM living in large cities, experienced the highest HIV
prevalence and incidence from 2010 to 2014 among all
KAPs. MSM in China are at exceptionally high risk for HIV
with the prevalence rising from 5.73% in 2010 to 7.75%
in 2014. These estimates are an unsurprising increase from
the findings reported in our previous study of MSM in 61 cities
conducted from February 2008 to September 2009 [25], which
found a prevalence of 4.9% (95% confidence interval: 4.7
to 5.1%).
During the same time period, HIV prevalence among DUs
followed a decreasing trend. Injection of opioids has histori-
cally been the main driver of the HIV epidemic in China,
but over the last decade, sexual transmission of HIV has
become the most common route of transmission. In our 2014
surveillance survey, ‘‘traditional’’ DUs had a nearly 10-fold
higher HIV prevalence (4.86%) than club DUs (0.47%). Drug
use trends are shifting from predominantly opioid use to
increasingly common use of club drugs such as methamphe-
tamine, MDMA (‘‘ecstasy’’) and ketamine. A previous study
of surveillance survey data reported a rapid increase in club
drug use from 1.3% of DUs in 2004 to 24.4% in 2011 [22]. Data
from the government have shown that 45% of registered
DUs used club drugs in China in 2014 [36]. The change in drug
use patterns presents a serious challenge for public health
programmes and has unclear implications for HIV control.
We found a low and decreasing HIV prevalence for FSWs
in China from 2010 to 2014. The decreasing trend among
FSWs may be because of the ongoing condom use campaign
in place since 2003 [37] and the turnover effect in this
population, which is approximately one-fifth to one-third of
FSWs [23].
For male patients of STD clinics, HIV prevalence increased
between 2010 and 2014. We believe there are several
possible mechanisms behind this trend. Increased engage-
ment in the Chinese sex industry, which has expanded rapidly
over the past three decades, is thought to be linked to aTa
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recent sharp rise in syphilis and other STDs [38]. The increase
in HIV prevalence among STD patients might also be attri-
butable to increased rates of diagnosis and case-reporting
practices of STDs [39] or changes in healthcare-seeking
behaviour among MSM and clients of FSWs. We also found
that STD patients in larger cities were more likely to be HIV-
positive, but it is unknown whether this reflects a true rise in
disease or better access to healthcare in larger cities.
In comparison to prevalence, incidence is a more direct
and sensitive indicator of epidemic dynamics. We estimated
that the MSM population had the highest overall incidence
during our study period among all high-risk groups, but
encouragingly, our incidence estimates show a decline from
0.74% in 2011 to 0.53% in 2014. When stratified by size of
cities, the HIV incidence among MSM living in large cities is
much higher than among MSM in smaller cities but has been
declining since 2012. In contrast, the incidence in smaller
cities is lower overall but has increased from 0.28% in 2012
to 0.39% in 2013 and to 0.36% in 2014. According to
a national report characterizing the HIV epidemic in China,
Figure 2. Geographical distribution of HIV prevalence among drug users (DU), female sex workers (FSW), men who have sex with men
(MSM) and male patients of sexually transmitted disease clinics (STD) in 2014.
Table 2. Case fatality among HIV positive KAPs detected during cross-sectional surveys from 2011 to 2013
2011a 2012a 2013a
KAP WB confirmed One year fatality rate* (%) WB confirmed One year fatality rate (%) WB confirmed One year fatality rate (%)
DUs 3161 1.6 3321 1.7 2996 2.4
FSW 212 0.9 384 0.5 293 0.3
MSM 1025 1.4 1610 0.9 1502 1.3
STD 243 5.3 398 2.5 375 2.1
aYears of cross-sectional survey; KAPkey affected population; WBwestern blot; DUsdrug users; FSW female sex workers;
MSMmen who have sex with men.
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HIV-positive MSM often choose to live in larger cities [40]. To
address the HIV epidemic among MSM, the Chinese govern-
ment has been expanding targeted campaigns to encourage
HIV testing and to increase engagement in care for urban
MSM populations since 2012. Our findings also highlight the
urgent need for a comprehensive response against the HIV
epidemic among MSM in smaller cities.
Our estimates of MSM HIV incidence are much lower than
previously published incidence rates measured through BED
(HIV-1 subtypes B, E, and D) capture enzyme immunoassay
(BED-CEIA) testing and prospective cohort studies in many
metropolitan areas, including Beijing, Chengdu and Shenyang
[41,42], but similar to an systematic review estimate of HIV
incidence among MSM of 0.98/100 person-years (95% con-
fidence interval: 0.70 to 1.25/100 person-years), as calculated
by Spectrum/EPP software [43]. BED-CEIA methods tend to
overestimate incidence when using cross-sectional survey
data compared with cohort study data [44,45] and are subject
to the sampling bias in a single cross-sectional survey.
Spectrum/EPP methods and our methods are based on similar
cross-sectional surveys, which may also be biased because of
disproportionate sampling of subgroups within populations.
We attempted to limit the impact of selection bias, allowing us
to produce reasonable estimates of HIV incidence, by using
survey data from multiple years across many sites and
adjusting for subgroups within the key populations.
Our HIV incidence estimates suggest that there has been
substantial progress in controlling the spread of HIV among
DUs. The incidence among DUs was less than 0.1% from 2011
to 2014. Nationwide harm reduction programmes in place
since 2006 [46] and the recent shift to increased club drug use
[22] might contribute to the low HIV incidence among DUs.
It is notable that, among those who use both traditional
and club drugs, HIV incidence increased from B0.001 in 2012
to 0.06% in 2013 and 0.35% in 2014. Club drug use has an
unclear relationship with HIV risk in China. Several studies
have suggested that a rise in club drug use led to a subsequent
increase in HIV prevalence through high-risk sexual behaviour
[47,48]. Additional research studies and public health initia-
tives are needed to understand and combat the HIV risk
associated with club drug use.
The low HIV incidence among FSWs and male patients
of STD clinics are not surprising. However, because of the
total population size of FSWs and their clients in China, even
a very low HIV incidence among FSWs can generate a large
number of new HIV infections. The latest surveillance data
showed that among the 103,501 newly-diagnosed HIV/AIDS
patients in 2014, about two-thirds (66.4%) self-reported as
having been infected through heterosexual contact [49].
Most past studies that estimated HIV incidence from cross-
sectional survey data have been conducted in generalized
epidemic settings in sub-Saharan Africa, where surveys were
Figure 3. HIV incidence among key populations from 2011 to 2014. DUsdrug users, FSW female sex workers, MSMmen who have
sex with men, STDmale patients of sexually transmitted disease clinics.
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household-based [21]. Because of the extremely low HIV
prevalence among the general population in China (esti-
mated to be less than 0.06% in 2011) [40], representative
household-based surveys are not generally feasible in China.
Compared to other studies in sub-Saharan Africa, our study
had several limitations. First, valid estimation of incidence
assumes that the cross-sectional surveys are representative of
the target population and not subject to significant selection
bias. Although we adjusted the HIV prevalence (Pi) estimates
by target population subgroups (e.g. low-fee venue-based
FSWs compared with FSWs who work in other settings),
during incidence calculations, we are not able to account for
all selection bias. Another potential source of bias is loss
to follow-up of participants who screen HIV-positive but fail
to obtain confirmation testing. These individuals are not
counted among the HIV-infected population in our analysis,
but we do not believe that loss to follow-up varied across
years and would have a minimal impact on our findings.
Second, because of the very low HIV prevalence among FSWs
and male STD patients, we found extremely low incidence
over our study period, which may be unreliable. Of note,
we assumed that HIV-infected and HIV-uninfected FSW leave
the FSW population at similar rates, as we could not find
published research on this topic. Third, the migration of KAPs
may be a source of bias in the HIV prevalence trends. In this
study, we attempted to reduce the impact of migration on
HIV incidence estimates by presenting HIV prevalence at the
national level based on data collected annually at same
sentinel sites; target sample sizes per survey site remained
consistent across study years.
Conclusions
In the context of concentrated epidemics, valid HIV incidence
estimates can be difficult to ascertain. From serial HIV
prevalence and case fatality data collected across China, we
used a mathematical model to estimate HIV incidence among
key high-risk populations, focussing on DUs, FSW, MSM and
male STD patients. We found large differences in prevalence
and incidence among the target populations, which has
implications for prioritizing and designing future HIV/AIDS
prevention efforts. In particular, our results highlight the high
HIV risk experienced by theMSM population. Future estimates
of HIV incidence can be improved by increasing the repre-
sentativeness of the surveillance surveys.
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